Pain
Conditions
Brief summary
Objective The aim of this study was to evaluate the effects of ShotBlocker administration during measles-mumps-rubella (MMR) vaccination on infants' pain level and mothers' satisfaction. Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between August and October 2024 using a randomized controlled experimental design. The study sample consisted of 60 infants who received MMR vaccination (ShotBlocker group: n = 30, control group: n = 30). Infants in the ShotBlocker group received ShotBlocker before vaccine injection, while infants in the control group received only routine vaccine injection. Infant information form, FLACC pain scale and Newcastle Satisfaction with Nursing Care Scale were used for data collection. Ethical principles were followed throughout the study.
Interventions
Apply ShotBlocker
Sponsors
Study design
Eligibility
Inclusion criteria
* He's 12 months old, * MMR vaccine will be administered, * growth-development is normal, * no analgesic medication was given during the day, * at least high school graduate * mothers who volunteered to participate in the study
Exclusion criteria
* Neurological disease, * a chronic disease, * allergy (egg allergy) * infants with symptoms of hyperthermia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Face, Legs, Activity, Crying, Consolability Pain Scala | pre-test post-test (approximately three months) | min-max (0-10), lower score means better result, reduce scale scores |
Countries
Turkey (Türkiye)